Press releases
- Dexcom Schedules Second Quarter 2024 Earnings Release and Conference Call for July 25, 2024 at 4:30 p.m. Eastern Time.
- Dexcom Expands AID Partnership Into The Netherlands
- Dexcom Showcases Extensive Clinical Data at ADA 2024 Demonstrating the Benefit of Dexcom CGM Use Among People With Type 2 Diabetes
- Dexcom G7 Now Connects Directly to Apple Watch in the U.S.
- Dexcom Wins Access to Dexcom ONE for 100,000 People Living With Type 2 Diabetes
- Nova Scotia Now Providing Coverage for Dexcom Continuous Glucose Monitoring Systems
- Dexcom Announces Upcoming Conference Presentation
- Tandem Mobi Insulin Pump Now Compatible with Dexcom G7 CGM
- Dexcom Launches Innovative New Sensor as Groundbreaking Report Reveals Alarming Rates of Anxiety and Depression in Those With Type 2 Diabetes
- Dexcom Reports First Quarter 2024 Financial Results
More ▼
Key statistics
On Tuesday, Dexcom Inc (DC4:FRA) closed at 103.94, -21.19% below its 52-week high of 131.88, set on Mar 26, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 103.94 |
---|---|
High | 103.94 |
Low | 103.94 |
Bid | 104.28 |
Offer | 105.06 |
Previous close | 103.94 |
Average volume | 302.80 |
---|---|
Shares outstanding | 397.68m |
Free float | 396.22m |
P/E (TTM) | 73.93 |
Market cap | 44.61bn USD |
EPS (TTM) | 1.52 USD |
Data delayed at least 15 minutes, as of Jul 02 2024 07:20 BST.
More ▼